SPINRAZA is an intrathecal injection administered by, or under the direction of, healthcare professionals experienced in performing lumbar punctures. The recommended dosage is 12 mg (5 mL) per administration.
Treatment with SPINRAZA begins with 4 loading doses. The first 3 doses are administered at 14-day intervals. The fourth dose should be administered 30 days after the third dose. After the starting dose period, a dose should be administered once every 4 months.
“I am happy I made the decision to get on SPINRAZA.”
The NDC for SPINRAZA is 64406-058-01
*Based on commercial patients, early access patients, and clinical trial participants through May 2022.